Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ADA 2020: Medtronic Explains Strategy To Return Growth To Diabetes Business

18 Jun 2020

• By Reed Miller

Business concept illustration of a running businessman racing with a businessman on rocket

Related Content

Market Intel: After A Year Of Partnerships, Insulin Pump Manufacturers Will Face Fierce Competition In 2020

09 Dec 2019

Medtronic CEO Omar Ishrak Announces Retirement; Geoff Martha Will Be New CEO

29 Aug 2019

ADA 2020: US Pivotal Trial Data Support Medtronic’s Next-Gen Insulin Pump

18 Jun 2020

Blackstone Invests $337M In Medtronic’s Diabetes R&D

18 Jun 2020

ACC 2020: Medtronic’s Resolute Onyx DES Meets Goals In US/Japan High Bleeding Risk Patients

09 Apr 2020

Related Companies

Medtronic plc

Additional Topics

Business Strategies Clinical Trials Companies Research & Development Diabetic Care Medical Device

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.